Format

Send to

Choose Destination
J Hepatol. 2018 Mar;68(3):597-600. doi: 10.1016/j.jhep.2017.09.008. Epub 2017 Sep 20.

Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

Author information

1
Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
2
Molecular Virology, Policlinic Foundation San Matteo, Pavia, Italy.
3
Department of Internal Medicine, University Hospital of Messina, Messina, Italy.
4
Infectious Diseases and Viral Hepatitis Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
5
Hygiene Unit, IRCCS AOU San Martino-IST, Genoa, Italy.
6
Laboratory of Microbiology and Virology, Amedeo di Savoia Hospital, ASL CittĂ  di Torino, Turin, Italy.
7
Virology, Siena University Hospital, Siena, Italy.
8
Hepatology Unit and Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses - University Hospital of Pisa, Italy.
9
Microbiology and Virology Unit, Sant'Orsola-Malpighi Hospital-Bologna, Italy.
10
Microbiology Laboratory, University Hospital, Modena, Italy.
11
Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy. Electronic address: ceccherini@med.uniroma2.it.
PMID:
28939133
DOI:
10.1016/j.jhep.2017.09.008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center